|
Dr. Harvey Pass Speech to Ban Asbestos Act, Washington D.C: "This disease, mesothelioma, is on the run."
(3/24/04)
I am proud to be an advocate for patients afflicted with asbestos
related cancers, and I am proud to represent a small cadre of intensely
devoted physicians, researchers, and nurses who, behind the scenes, with
far too little resources are trying to gain insight into the management of
this disease. More...
Malignant Pleural Mesothelioma: Surgical Roles and Novel Therapies
(2/7/02)
Dr. Harvey Pass' comprehensive review of the
literature on mesothelioma diagnosis and treatment is a must read,
for both doctors and patients alike. The article carefully reviews
the diagnostic and therapeutic options for patients from the time of
initial symptoms onward. It addresses without bias the pros and cons
of the various surgical options, with or without chemotherapy and
radiation. More...
|
Date of Preparation: March 21, 2003
* Updated August 23, 2005
* * *
* * * *
CURRICULUM VITAE
Harvey I. Pass M.D.
Professor and Chief,
Division of Thoracic Surgery and Thoracic Oncology
Department of Cardiothoracic Surgery
NYU School of Medicine and Comprehensive Cancer Center
530 1st Avenue, 9V
New York, New York 10016
Phone:
212.263.7417
OFFICE ADDRESS:
NYU School of Medicine and Comprehensive
Cancer Center
530 1st Avenue, 9V
New York, New York 10016
PERSONAL DATA:
Birth Date: 12/26/49
Birth Place: Baltimore, Maryland
Age: 51
Married Spouse: Helen A. (Pogrebniak) Pass M.D.
Daughter: Allexandra R.
Son: Eric C.
EDUCATION:
Johns Hopkins University,
Baltimore, Maryland
1967-1970 , B.A.
Duke University Medical School
Durham, North Carolina,
1970-1973, M.D.
|
TRAINING: |
1973-1974
|
Duke University Medical Center
Straight Surgical Internship |
|
|
|
|
|
|
1974-1975 |
Duke University Medical Center
Straight Surgical Residency |
|
|
|
|
|
|
1975-1977 |
United States Public Health Service
Hospital
Staten Island, New York
Staff Surgeon |
|
|
|
|
|
|
1977-1980 |
University of Mississippi Medical
Center
Senior and Chief Resident
Division of Surgery |
|
|
|
|
|
|
1980-1982 |
Medical University of South
Carolina
Senior Residency and Chief Resident
Division of Cardiothoracic Surgery |
|
|
|
|
|
FACULTY |
|
|
|
APPOINTMENTS: |
1982-1983 |
Assistant Professor
Medical University of South Carolina
Division of Cardiothoracic Surgery
Charleston, South Carolina |
|
|
|
|
|
|
1983-1986 |
Senior Staff Fellow, Thoracic
Oncology Section
Surgery Branch
National Cancer Institute/NIH, Bethesda |
|
|
|
|
|
|
1983 - 1996 |
Assistant Professor of Surgery
Uniformed Services University of the
Health Sciences
Bethesda, Maryland |
|
|
|
|
|
PROFESSIONAL |
|
|
|
APPOINTMENTS: |
1986 - 1996
|
Head, Thoracic Oncology Section and
Tenured Senior Investigator
Surgery Branch, National Cancer Institute
Bethesda, Maryland |
MAJOR PROFESSIONAL SOCIETIES:
American Surgical Association
Association of Military Surgeons
Association of Academic Surgeons
Society of Thoracic Surgeons
Society for Surgical Oncology
Fellow of the American College of Surgeons
Southern Thoracic Surgical Association
Society of University Surgeons
Surgical Biology Club III
American College of Chest Physicians
American Association of Thoracic Surgeons
International Mesothelioma Group
International Association for the Study of Lung Cancer
International Early Lung Cancer Action Project
International Working Group on Pulmonary Metastases
American Society of Clinical Oncology
American Association for Cancer Research
Thoracic Surgery Club
LICENSURE
AND BOARD CERTIFICATION:
1974 - National Board of Medical Examiners
1981 - American Board of Surgery
1983 - American Board of Thoracic Surgery
1992 - American Board of Thoracic Surgery (recertified)
2001 - American Board of Thoracic Surgery (recertified)
HONORS/AWARDS:
|
1967 -
|
Cum Laude (High School) |
|
1970 -
|
Alpha Epsilon Delta, Pre Medical
Society
Phi Beta Kappa,Johns Hopkins University
|
|
1979 -
|
Mississippi Regional Trauma Award,
First Place Winner Annual Meeting of the Mississippi Medical Society |
|
1980 - |
Conrad Jobst Award, First Place
Winner, Southeast Surgical Congress
"Comparison of External and Internal Cardiac Massage" |
|
1983 - |
Conrad Jobst Award, Third Place
Winner, Southeast Surgical Congress
"Augmentation of External Cardiac Massage with the Mast Suit" |
|
1984 - |
Rowe Foundation Award for
outstanding article by an Institution-Based Physician in the Journal of the South
Carolina Medical Association, "Radioactive Microspheres: A useful tool in the
investigation of myocardial ischemia". |
|
1989 - |
President's Award, Southern
Thoracic Surgical Association |
|
1991 - |
NIH Directors Award |
|
1992 - |
Best Doctors in America
(Naifeh S and Smith G, eds): Thoracic Oncologic Surgery |
|
1992 -
|
Best Cancer Specialists in the U.S.
Good Housekeeping, October 1992 |
|
1995 -
|
Hufnagle Award for benchwork
research performed by a Georgetown General Surgery Resident |
|
1996 -
|
First Place: Washington Academy of
Sciences Award |
|
1999 -
|
318 Best Cancer Specialists for
Women in the U.S. Good Housekeeping, March 1999 |
|
2000 - |
Presidents Award for Clinical
Research, Karmanos Cancer Institute |
|
2001 -
|
America’s Top Doctors.
Castle
Connoly’s Guide |
|
2002 - |
America’s Top Doctors.
Castle
Connoly’s Guide |
SERVICE:
1. Patient Care: General and Cardiothoracic Surgery,
specifically Thoracic Oncology
2. Professional Consultation:
a. Public presentations as an expert in discipline
Mesothelioma. Defense Research
Institute Meeting. New York, NY, 1994
b. Testimony before public bodies:
Defense of PDT for Lung Cancer: ODAC
meeting, FDA, September 1997
Defense of PDT for Lung Cancer: ODAC
meeting, FDA, September 1998
c.. Consulting to public agencies, foundations, professional
associations
Site visit Member for review of the Lung
Cancer Study Group, 1986
Surgical expert and speaker for ALCASE,
1998
Chairman, Scientific Advisory Board,
Mesothelioma Applied Research Foundation (MARF)
Medical Advisory Board, ALCASE 2000 -
d. Consulting to private enterprises:
Light Medicine, Inc.
PDT Inc.
Pharmacyclics
Quadra Logics Technologies
Jansen Pharmacia
Chiron-Bayer
Sanofi Pharmaceuticals
Alfacell
Battelle
Xillix
Lilly
3. Journal/Editorial activity
a. Editorships
Guest Editor: Adjunctive and
Alternative Treatment of Bronchogenic Lung Cancer,
Chest
Surgery Clinics of North America, 1:1, August 1991
Surgical Editor, Clinical Lung Cancer
, 2001-
Thoracic Surgery Editor,
Annals of
Surgical Oncology, 2003-
b. Editorial board memberships:
Journal
of the National Cancer Institute, 1990-1994
Annals of Surgical Oncology,
1993-
Surgical Oncology, 1993-
Journal of Surgical Research,
1995-2003
Clinical Lung Cancer, 1999-
Current Treatment Options in
Oncology, 1999-
Clinical Cancer Research, 2001-
c. Guest reviewer:
Cancer Research
Annals of Thoracic Surgery
Journal of Thoracic and
Cardiovascular Surgery
Chest
British Medical Journal
New England Journal of Medicine
Journal of Clinical Oncology
JAMA
Clinical Cancer Research
The Cancer Journal of Scientific
American
Cancer
Clinical Cancer Research
The Oncologist
International Journal of Cancer
Clinical Lung Cancer
Journal of the National Cancer
Institute
Oncogene
4. Other professionally related service
1997 - Karmanos Cancer Institute Program Leader, Thoracic
Oncology
1997 - Karmanos Cancer Institute Clinical Cancer Trials Committee
2002 – Karmanos Cancer Institute Associate Director for Clinical Research
2002 – Karmanos Cancer Institute CEO and President Search Committee
5. National and international boards and committees
a. Positions held in professional associations
1991 - 1996 NCI
representative, American Joint Commission on Cancer
1991 - 1994 Program Committee, Southern
Thoracic Surgical Association
1991 - 1995
Consultant, American Board of Thoracic Surgeons
1995 - 1997 Counselor at Large, Southern
Thoracic Surgical Association
1996 - 1998 Young Members Committee,
American Association of Thoracic Surgeons
1998 - 2000 Residents Committee,
American Association of Thoracic Surgeons
1998 - 2000 Thoracic Surgery Foundation
for Research and Education, Finance committee
1998- Executive Committee, International
Mesothelioma Interest Group
1999- Chairman, Scientific Advisory
Board, Mesothelioma Applied Research Foundation (MARF)
2001- Scientific Program Committee:
International Association for the Study of Lung Cancer
2001- Lung Committee, American Society
for Clinical Oncology
b. Memberships/offices held in public agencies related to
discipline:
1997 - Michigan
Lung Cancer Advisory Committee
1998 - Michigan Thoracic Society
1998 - Detroit Academy of Surgery
1998 - Detroit Surgical Association
6. State and local boards and committees:
1997 - Michigan Lung Cancer Advisory Committee
1997 - Chairman, Detection/Screening of Lung Cancer, Michigan Lung Cancer Advisory
Committee
TEACHING:
1. Years at Wayne State: 7.0
2. Years at other colleges/universities
1982 - 1983
Assistant Professor Medical University
of South Carolina
Division of Cardiothoracic Surgery
Charleston, South Carolina
1983 - 1996
Assistant Professor of Surgery
Uniformed Services University of the
Health Sciences Bethesda, Maryland
3. Courses taught at Wayne State in last five years: Cancer
Biology
4. Essays/Theses/Dissertations directed: none
5. Course or Curriculum development:
a. Early Lung Cancer: Strategic Initiatives for
Molecular Diagnosis and Treatment, Sommersett Inn, June 15-17, 2000
6. Course materials (unpublished): none
GRANT SUPPORT:
|
(Pass, H, Principal Investigator)
Olympus America |
|
04/01/99 - 10/01/01
$20,000 |
|
10% |
|
Use of Sputum Induction and
Fluorescence Bronchoscopy
for Airway Surveillance and Study of Intermediate Markers
of Neoplasia in Asbestos Exposed Individuals |
|
|
|
|
|
|
|
|
|
|
|
(Pass, H, Principal Investigator)
|
|
10/98 - 10/01 |
|
20% |
|
Department of Veterans Affair Merit
Review
Detection of SV40 Like Viral DNA in Human Mesothelioma |
|
$93,000/year x 3 years |
|
|
|
|
|
|
|
|
|
(Pass, H, Principal
Investigator)
INSPIRE Pharmaceuticals |
|
05/00 – 04/01
$32,593.75 |
|
2% |
|
Evaluation of Uridine
5’-Triphosphate Solution
for Inhalation (UTP) as an Adjunct in the Diagnosis
of Lung Cancer by Sputum Cytology |
|
|
|
|
|
|
|
|
|
|
|
(Pass, H, Principal Investigator)
Eli Lilly and Company |
|
07/99 – 06/02
$3,668/patient |
|
2% |
|
A single-blind randomized phase
3 trial
of MTA plus Cisplatin versus Cisplatin
with malignant pleural mesothelioma
|
|
|
|
|
|
|
|
|
|
|
|
(Kucuk, O, Principal
Investigator)
Pass, H, Co-Investigator
|
|
01/01 – 06/30/03
$758,959/year |
|
20% |
|
NO1-CN-05022-57
NIH Masters Agreement
Work Statement #68
Zileuton for Bronchial Dysplasia |
|
|
|
|
|
|
|
|
|
|
|
(Pass, H, Principal
Investigator) |
|
01/01 -
|
|
|
|
Rapid Assessment for
Intervention Development (RAID)
NIH Contractual Agreement- approximately $1.4 million
Use of Vac-Tag for Malignant Pleural Mesothelioma |
|
|
|
|
|
|
|
|
|
|
|
(Schwartz, A.)
Pass, H, Co-Investigator |
|
07/01/00 – 06/30/05
$400,000 |
|
5% |
|
NCI
Adenocarcinoma of the Lung in Women |
|
|
|
|
|
|
|
|
|
|
|
(Pass, H.)
|
|
4/01/01-3/31-02 |
|
10% |
|
NCI-Early Detection Research
Network (Part of UO1)
Gene Arrays and Methylation in Mesothelioma |
|
$100,000 |
|
|
|
|
|
|
|
|
|
(Phillips, M, Principal
Investigator)
(Pass, H Consultant) |
|
7/01/01-06/30/03
$700,000 |
|
|
|
NCI-SBIR
Detection of Lung Cancer using Exhaled Gas Determination |
|
|
|
|
|
|
|
|
|
|
|
(Pass, H, Principal
Investigator) |
|
4/2002-3/2005 |
|
|
|
Veterans Administration,
Merit Review
Osteonectin and TIMP1 in Mesothelioma |
|
$363,900 |
|
|
|
|
|
|
|
|
|
(Pass, H, Principal
Investigator) |
|
11/2001 – 7/2003 |
|
|
|
KCI Virtual Discovery Grant
Racial Differences in Lung Cancer |
|
$330,000 |
|
|
|
|
|
|
|
|
|
(Wali, A Principal
Investigator; Pass H Co-Investigator) |
|
4/2003-3/2006 |
|
|
|
Veterans Administration
Merit Review
Intellectin Expression in Mesothelioma |
|
$398,000 |
|
|
PROTOCOLS (Principle Investigator)
National Cancer Institute
Intraoperative Radiation Therapy for Thoracic Malignancies, 1984-1986
Phase III Randomized Trial of Neoadjuvant Chemotherapy for NSCLC: 1986-1991
Intraoperative Photodynamic Therapy for Thoracic Malignancies
Phase I: 1990-1993
Phase III: 1993-1996
Photodynamic Therapy for Bronchial Obstruction, Phase II: 1987-1996
Immunochemotherapy for Pleural Mesothelioma, Phase II: 1990-1993
Phase I Trial of Isolated Lung Perfusion with Tumor Necrosis Factor: 1994-1996
Phase II Trial of Induction IFN, 5FU, Cisplatin, and Leucovorin for Esophageal
Cancer: 1992-1996
Karmanos Cancer Institute
Adriamycin vs Onconase for mesothelioma, ALFACELL:
Early Lung Cancer Detection for Stage I NSCLC resected, CHIRON: BAYER,
MTA-Platinum vs Platinum for mesothelioma, LILLY
Lu-TEX photosensitization for endobronchial disease, IND awarded
Tetrathiomolybdate after resection of Pleural mesothelioma (Investigator initiated)
A Breath Test for Lung Cancer (NIH grant)
Proteomics of Mesothelioma Pleural Effusions (Ciphergen) (Investigator Initiated)
Computerized Tomographic Screening for Lung Cancer (Investigator Initiated, part of
International Early Lung Cancer Action Project)
Publications
1. Original observations in refereed journals
1. Friedberg, J. S., Mick, R., Stevenson, J., Metz, J., Zhu,
T., Buyske, J., Sterman, D. H., Pass, H. I., Glatstein, E., and Hahn, S. M. A phase I
study of Foscan-mediated photodynamic therapy and surgery in patients with mesothelioma.
Ann.Thorac.Surg., 75: 952-959, 2003.
2. Lonardo, F., Pass, H. I., and Lucas, D. R.
Immunohistochemistry Frequently Detects c-Kit Expression in Pulmonary Small Cell Carcinoma
and May Help Select Clinical Subsets for a Novel Form of Chemotherapy.
Appl.Immunohistochem.Mol.Morphol., 11: 51-55, 2003.
3. Lucas, D. R., Pass, H. I., Madan, S. K., Adsay, N. V.,
Wali, A., Tabaczka, P., and Lonardo, F. Sarcomatoid mesothelioma and its histological
mimics: a comparative immunohistochemical study. Histopathology, 42: 270-279, 2003.
4. Bocchetta, M., Miele, L., Pass, H. I., and Carbone, M.
Notch-1 induction, a novel activity of SV40 required for growth of SV40-transformed human
mesothelial cells. Oncogene, 22: 81-89, 2003.
5. Pass, H. I. General thoracic surgery and science: it all
takes time. Ann.Thorac.Cardiovasc.Surg., 8: 251-252, 2002.
6. Pass, H. I. Pleural mesothelioma in 2002: going somewhere
very slowly. J Thorac.Cardiovasc.Surg., 124: 1074-1077, 2002.
7. Friedel, G., Pastorino, U., Ginsberg, R. J., Goldstraw,
P., Johnston, M., Pass, H., Putnam, J. B., and Toomes, H. Results of lung metastasectomy
from breast cancer: prognostic criteria on the basis of 467 cases of the International
Registry of Lung Metastases. Eur.J Cardiothorac.Surg., 22: 335-344, 2002.
8. Pass, H. I. Photodynamic therapy in thoracic surgery.
Ann.Thorac.Surg., 73: 2012-2013, 2002.
9. Lechner, J. F., Wang, Y., Siddiq, F., Fugaro, J. M., Wali,
A., Lonardo, F., Willey, J. C., Harris, C. C., and Pass, H. I. Human lung cancer cells and
tissues partially recapitulate the homeobox gene expression profile of embryonic lung.
Lung Cancer, 37: 41-47, 2002.
10. Pass, H. I. Biology of metastatic disease.
Semin.Thorac.Cardiovasc.Surg., 14: 10-17, 2002.
11. Bright, R. K., Kimchi, E. T., Shearer, M. H., Kennedy, R.
C., and Pass, H. I. SV40 Tag-specific cytotoxic T lymphocytes generated from the
peripheral blood of malignant pleural mesothelioma patients. Cancer Immunol.Immunother.,
50:
682-690, 2002.
12. Foddis, R., De Rienzo, A., Broccoli, D., Bocchetta, M.,
Stekala, E., Rizzo, P., Tosolini, A., Grobelny, J. V., Jhanwar, S. C., Pass, H. I., Testa,
J. R., and Carbone, M. SV40 infection induces telomerase activity in human mesothelial
cells. Oncogene, 21: 1434-1442, 2002.
13. Marom, E. M., Erasmus, J. J., Pass, H. I., and Patz, E.
F., Jr. The role of imaging in malignant pleural mesothelioma. Semin.Oncol,
29:
26-35, 2002.
14. Carbone, M. and Pass, H. I. Re: Debate on the link
between SV40 and human cancer continues. J Natl.Cancer Inst., 94: 229-230, 2002.
15. Toyooka, S., Pass, H. I., Shivapurkar, N., Fukuyama, Y.,
Maruyama, R., Toyooka, K. O., Gilcrease, M., Farinas, A., Minna, J. D., and Gazdar, A. F.
Aberrant methylation and simian virus 40 tag sequences in malignant mesothelioma. Cancer
Res., 61: 5727-5730, 2001.
16. Pass, H. I., Kalemkerian, G., and Bright, R. K. Novel
molecular and immunotherapeutic strategies for lung cancer. Chest Surg.Clin N.Am.,
11:
189-212, ix, 2001.
17. Imperiale, M. J., Pass, H. I., and Sanda, M. G. Prospects
for an SV40 vaccine. Semin.Cancer Biol., 11: 81-85, 2001.
18. Rizzo, P., Bocchetta, M., Powers, A., Foddis, R.,
Stekala, E., Pass, H. I., and Carbone, M. SV40 and the pathogenesis of mesothelioma.
Semin.Cancer Biol., 11: 63-71, 2001.
19. Lechner, J. F., Fugaro, J. M., Wong, Y., Pass, H. I.,
Harris, C. C., and Belinsky, S. A. Perspective: cell differentiation theory may advance
early detection of and therapy for lung cancer. Radiat.Res., 155: 235-238, 2001.
20. Wang, Y., Fugaro, J. M., Siddiq, F., Goparaju, C. M.,
Lonardo, F., Wali, A., Lechner, J. F., and Pass, H. I. A simple method for generating full
length cDNA from low abundance partial genomic clones. BMC.Mol.Biol., 1: 2, 2000.
21. Bocchetta, M., Di, R., I, Powers, A., Fresco, R.,
Tosolini, A., Testa, J. R., Pass, H. I., Rizzo, P., and Carbone, M. Human mesothelial
cells are unusually susceptible to simian virus 40-mediated transformation and asbestos
cocarcinogenicity. Proc.Natl.Acad.Sci.U.S.A, 97: 10214-10219, 2000.
22. Marrogi, A., Pass, H. I., Khan, M., Metheny-Barlow, L.
J., Harris, C. C., and Gerwin, B. I. Human mesothelioma samples overexpress both
cyclooxygenase-2 (COX-2) and inducible nitric oxide synthase (NOS2): in vitro
antiproliferative effects of a COX-2 inhibitor. Cancer Res., 60: 3696-3700, 2000.
23. Carbone, M., Rizzo, P., and Pass, H. Simian virus 40: the
link with human malignant mesothelioma is well established. Anticancer Res.,
20:
875-877, 2000.
24. Pass, H. I. Lung cancer surveillance: new technologies
and novel strategies. Ann.Surg.Oncol, 7: 171-173, 2000.
25. Shivapurkar, N., Wiethege, T., Wistuba, I. I., Salomon,
E., Milchgrub, S., Muller, K. M., Churg, A., Pass, H., and Gazdar, A. F. Presence of
simian virus 40 sequences in malignant mesotheliomas and mesothelial cell proliferations.
J Cell Biochem., 76: 181-188, 1999.
26. Rizzo, P., Carbone, M., Fisher, S. G., Matker, C.,
Swinnen, L. J., Powers, A., Di, R., I, Alkan, S., Pass, H. I., and Fisher, R. I. Simian
virus 40 is present in most United States human mesotheliomas, but it is rarely present in
non-Hodgkin's lymphoma. Chest, 116: 470S-473S, 1999.
27. Pass, H. I., Robinson, B. W., Testa, J. R., and Carbone,
M. Emerging translational therapies for mesothelioma. Chest, 116: 455S-460S, 1999.
28. Herscher, L. L., Cook, J. A., Pacelli, R., Pass, H. I.,
Russo, A., and Mitchell, J. B. Principles of chemoradiation: theoretical and practical
considerations. Oncology (Huntingt), 13: 11-22, 1999.
29. Hirvonen, A., Mattson, K., Karjalainen, A., Ollikainen,
T., Tammilehto, L., Hovi, T., Vainio, H., Pass, H. I., Di, R., I, Carbone, M., and
Linnainmaa, K. Simian virus 40 (SV40)-like DNA sequences not detectable in finnish
mesothelioma patients not exposed to SV40-contaminated polio vaccines. Mol.Carcinog.,
26:
93-99, 1999.
30. Ohta, Y., Shridhar, V., Bright, R. K., Kalemkerian, G.
P., Du, W., Carbone, M., Watanabe, Y., and Pass, H. I. VEGF and VEGF type C play an
important role in angiogenesis and lymphangiogenesis in human malignant mesothelioma
tumours. Br.J Cancer, 81: 54-61, 1999.
31. Shridhar, V., Staub, J., Huntley, B., Cliby, W., Jenkins,
R., Pass, H. I., Hartmann, L., and Smith, D. I. A novel region of deletion on chromosome
6q23.3 spanning less than 500 Kb in high grade invasive epithelial ovarian cancer.
Oncogene, 18: 3913-3918, 1999.
32. Giuffrida, A., Vianale, G., Di Muzio, M., Pass, H. I.,
Coletti, A., Birarelli, P., Procopio, A., and Modesti, A. Modulation of integrin
expression on mesotheliomas: the role of different histotypes in invasiveness. Int.J
Oncol, 15: 437-442, 1999.
33. Carbone, M., Fisher, S., Powers, A., Pass, H. I., and
Rizzo, P. New molecular and epidemiological issues in mesothelioma: role of SV40. J Cell
Physiol, 180: 167-172, 1999.
34. Ohta, Y., Shridhar, V., Kalemkerian, G. P., Bright, R.
K., Watanabe, Y., and Pass, H. I. Thrombospondin-1 expression and clinical implications in
malignant pleural mesothelioma. Cancer, 85: 2570-2576, 1999.
35. Scarpa, S., Giuffrida, A., Fazi, M., Coletti, A.,
Palumbo, C., Pass, H. I., Procopio, A., and Modesti, A. Migration of mesothelioma cells
correlates with histotype-specific synthesis of extracellular matrix. Int.J Mol.Med.,
4:
67-71, 1999.
36. Xu, L., Flynn, B. J., Ungar, S., Pass, H. I., Linnainmaa,
K., Mattson, K., and Gerwin, B. I. Asbestos induction of extended lifespan in normal human
mesothelial cells: interindividual susceptibility and SV40 T antigen. Carcinogenesis,
20:
773-783, 1999.
37. Friedel, G., Pastorino, U., Buyse, M., Ginsberg, R. J.,
Girard, P., Goldstraw, P., Johnston, M., McCormack, P., Pass, H., Putnam, J. B., and
Toomes, H. [Resection of lung metastases: long-term results and prognostic analysis based
on 5206 cases--the International Registry of Lung Metastases]. Zentralbl.Chir,
124:
96-103, 1999.
38. Watts, A. M., Shearer, M. H., Pass, H. I., Bright, R. K.,
and Kennedy, R. C. Comparison of simian virus 40 large T antigen recombinant protein and
DNA immunization in the induction of protective immunity from experimental pulmonary
metastasis. Cancer Immunol.Immunother., 47: 343-351, 1999.
39. DeLaney, T. F., Smith, P. D., Thomas, G. F., Tochner, Z.
A., Sindelar, W. F., Pass, H. I., Harrington, F. S., Bonner, R. F., and Mitchell, J. B. A
light-diffusing device for intraoperative photodynamic therapy in the peritoneal or
pleural cavity. J Clin Laser Med.Surg., 9: 361-366, 1991.
40. Pass, H. I. Pancreatic cancer, gene delivery, and
targets: the search for specificity. Ann.Surg.Oncol, 5: 667-669, 1998.
41. Pass, H. I., Donington, J. S., Wu, P., Rizzo, P.,
Nishimura, M., Kennedy, R., and Carbone, M. Human mesotheliomas contain the simian
virus-40 regulatory region and large tumor antigen DNA sequences. J
Thorac.Cardiovasc.Surg., 116: 854-859, 1998.
42. Bright, R. K., Shearer, M. H., Pass, H. I., and Kennedy,
R. C. Immunotherapy of SV40 induced tumours in mice: a model for vaccine development.
Dev.Biol.Stand., 94: 341-353, 1998.
43. Pass, H. I., Mew, D. J., Carbone, M., Donington, J. S.,
Baserga, R., and Steinberg, S. M. The effect of an antisense expression plasmid to the
IGF-1 receptor on hamster mesothelioma proliferation. Dev.Biol.Stand.,
94: 321-328,
1998.
44. Carbone, M., Stach, R., Di, R., I, Pass, H. I., and
Rizzo, P. Simian virus 40 oncogenesis in hamsters. Dev.Biol.Stand., 94: 273-279,
1998.
45. Pass, H., Rizzo, P., Donington, J., Wu, P., and Carbone,
M. Further validation of SV40-like DNA in human pleural mesotheliomas. Dev.Biol.Stand.,
94:
143-145, 1998.
46. Rizzo, P., Di, R., I, Stach, R., Mutti, L., Picci, P.,
Kast, W. M., Pass, H. I., and Carbone, M. Evidence for and implications of SV40-like
sequences in human mesotheliomas and osteosarcomas. Dev.Biol.Stand., 94: 33-40,
1998.
47. Temeck, B. K., Wexler, L. H., Steinberg, S. M., McClure,
L. L., Horowitz, M. A., and Pass, H. I. Reoperative pulmonary metastasectomy for
sarcomatous pediatric histologies. Ann.Thorac.Surg., 66 : 908-912, 1998.
48. Rizzo, P., Di, R., I, Powers, A., Matker, C. M., Zhang,
A., Mutti, L., Kast, W. M., Pass, H., and Carbone, M. The detection of simian virus 40 in
human tumors by polymerase chain reaction. Monaldi Arch.Chest Dis., 53: 202-210,
1998.
49. Matker, C. M., Rizzo, P., Pass, H. I., Di, R., I, Powers,
A., Mutti, L., Kast, W. M., and Carbone, M. The biological activities of simian virus 40
large-T antigen and its possible oncogenic effects in humans. Monaldi Arch.Chest Dis.,
53:
193-197, 1998.
50. Sgrignoli, A., Abati, A., Pass, H., Lebovics, R., and
Hijazi, Y. Metastatic mesothelioma presenting as a salivary gland neoplasm. Acta Cytol.,
42:
818-820, 1998.
51. Pass, H. I. Surgical management of pulmonary metastases.
Curr.Opin.Oncol, 10: 146-150, 1998.
52. Shaw, G. L., Falk, R. T., Frame, J. N., Weiffenbach, B.,
Nesbitt, J. C., Pass, H. I., Caporaso, N. E., Moir, D. T., and Tucker, M. A. Genetic
polymorphism of CYP2D6 and lung cancer risk. Cancer Epidemiol.Biomarkers Prev.,
7:
215-219, 1998.
53. Williams, K. S., Susla, G., Temeck, B. K., Piscitelli, S.
C., and Pass, H. I. Pharmacokinetics of fentanyl during hyperthermic, isolated lung
perfusion. South.Med.J, 91: 261-265, 1998.
54. Pass, H. I. and Temeck, B. A. Biology of metastatic
disease. Chest Surg.Clin N.Am., 8: 1-11, 1998.
55. Watts, A. M., Shearer, M. H., Pass, H. I., and Kennedy,
R. C. Development of an experimental murine pulmonary metastasis model incorporating a
viral encoded tumor specific antigen. J Virol.Methods, 69: 93-102, 1997.
56. Pass, H. I., Temeck, B. K., Kranda, K., Steinberg, S. M.,
and Feuerstein, I. R. Preoperative tumor volume is associated with outcome in malignant
pleural mesothelioma. J Thorac.Cardiovasc.Surg., 115: 310-317, 1998.
57. Herscher, L. L., Hahn, S. M., Kroog, G., Pass, H.,
Temeck, B., Goldspiel, B., Cook, J., Mitchell, J. B., and Liebmann, J. Phase I study of
paclitaxel as a radiation sensitizer in the treatment of mesothelioma and non-small-cell
lung cancer. J Clin Oncol, 16: 635-641, 1998.
58. Pass, H. I., Temeck, B. K., Kranda, K., Thomas, G.,
Russo, A., Smith, P., Friauf, W., and Steinberg, S. M. Phase III randomized trial of
surgery with or without intraoperative photodynamic therapy and postoperative
immunochemotherapy for malignant pleural mesothelioma. Ann.Surg.Oncol,
4: 628-633,
1997.
59. Mawhorter, S., Temeck, B., Chang, R., Pass, H., and Nash,
T. Nonsurgical therapy for pulmonary hydatid cyst disease. Chest, 112: 1432-1436,
1997.
60. Carbone, M., Rizzo, P., and Pass, H. I. Simian virus 40,
poliovaccines and human tumors: a review of recent developments. Oncogene,
15:
1877-1888, 1997.
61. Wagner, J. R., Merino, M. J., Pass, H. I., Linehan, W.
M., and Walther, M. M. Pulmonary infarcts can mimic pulmonary metastases from renal
cancer. J Urol., 158: 1688-1690, 1997.
62. Walther, M. M., Yang, J. C., Pass, H. I., Linehan, W. M.,
and Rosenberg, S. A. Cytoreductive surgery before high dose interleukin-2 based therapy in
patients with metastatic renal cell carcinoma. J Urol., 158: 1675-1678, 1997.
63. De Luca, A., Baldi, A., Esposito, V., Howard, C. M.,
Bagella, L., Rizzo, P., Caputi, M., Pass, H. I., Giordano, G. G., Baldi, F., Carbone, M.,
and Giordano, A. The retinoblastoma gene family pRb/p105, p107, pRb2/p130 and simian
virus-40 large T-antigen in human mesotheliomas. Nat.Med., 3: 913-916, 1997.
64. Carbone, M., Rizzo, P., Grimley, P. M., Procopio, A.,
Mew, D. J., Shridhar, V., de Bartolomeis, A., Esposito, V., Giuliano, M. T., Steinberg, S.
M., Levine, A. S., Giordano, A., and Pass, H. I. Simian virus-40 large-T antigen binds p53
in human mesotheliomas. Nat.Med., 3: 908-912, 1997.
65. Abati, A., Sanford, J., Fetsch, P., and Pass, H.
Detection of aneuploidy in mesothelioma cell lines by fluorescence in situ hybridization
(FISH). Diagn.Cytopathol., 16: 375-377, 1997.
66. Pass, H. I., Kranda, K., Temeck, B. K., Feuerstein, I.,
and Steinberg, S. M. Surgically debulked malignant pleural mesothelioma: results and
prognostic factors. Ann.Surg.Oncol, 4: 215-222, 1997.
67. Leschek, E. W., Doppman, J. L., Pass, H. I., and Cutler,
G. B., Jr. Localization by venous sampling of occult chorionic gonadotropin-secreting
tumor in a boy with mosaic Klinefelter's syndrome and precocious puberty. J Clin
Endocrinol.Metab, 81: 3825-3828, 1996.
68. Doppman, J. L., Skarulis, M. C., Chen, C. C., Chang, R.,
Pass, H. I., Fraker, D. L., Alexander, H. R., Niederle, B., Marx, S. J., Norton, J. A.,
Wells, S. A., and Spiegel, A. M. Parathyroid adenomas in the aortopulmonary window.
Radiology, 201: 456-462, 1996.
69. Temeck, B. K., Koong, S. S., Reynolds, J. C., and Pass,
H. I. Somatostatin analogue in the localization and treatment of bronchial carcinoid
tumours. Surg.Oncol, 5: 195-200, 1996.
70. Pompetti, F., Rizzo, P., Simon, R. M., Freidlin, B., Mew,
D. J., Pass, H. I., Picci, P., Levine, A. S., and Carbone, M. Oncogene alterations in
primary, recurrent, and metastatic human bone tumors. J Cell Biochem.,
63: 37-50,
1996.
71. Howe, S. R., Pass, H. I., Ethier, S. P., Matthews, W. J.,
and Walker, C. Presence of an insulin-like growth factor I autocrine loop predicts uterine
fibroid responsiveness to tamoxifen. Cancer Res., 56: 4049-4055, 1996.
72. Pass, H. I., Mew, D. J., Carbone, M., Matthews, W. A.,
Donington, J. S., Baserga, R., Walker, C. L., Resnicoff, M., and Steinberg, S. M.
Inhibition of hamster mesothelioma tumorigenesis by an antisense expression plasmid to the
insulin-like growth factor-1 receptor. Cancer Res., 56: 4044-4048, 1996.
73. Carbone, M., Rizzo, P., Procopio, A., Giuliano, M., Pass,
H. I., Gebhardt, M. C., Mangham, C., Hansen, M., Malkin, D. F., Bushart, G., Pompetti, F.,
Picci, P., Levine, A. S., Bergsagel, J. D., and Garcea, R. L. SV40-like sequences in human
bone tumors. Oncogene, 13: 527-535, 1996.
74. Temeck, B. K., Liebmann, J. E., Theodossiou, C.,
Steinberg, S. M., Cook, J. A., Metz, D. C., Shawker, T. H., Allegra, C. J., Russo, A., and
Pass, H. I. Phase II trial of 5-fluorouracil, leucovorin, interferon-alpha-2a, and
cisplatin as neoadjuvant chemotherapy for locally advanced esophageal carcinoma. Cancer,
77:
2432-2439, 1996.
75. Garza, O. T., Abati, A., Sindelar, W. F., Pass, H. I.,
and Hijazi, Y. M. Cytologic effects of photodynamic therapy in body fluids.
Diagn.Cytopathol., 14: 356-361, 1996.
76. Pass, H. I., Mew, D. J., Kranda, K. C., Temeck, B. K.,
Donington, J. S., and Rosenberg, S. A. Isolated lung perfusion with tumor necrosis factor
for pulmonary metastases. Ann.Thorac.Surg., 61: 1609-1617, 1996.
77. Johnson, B. E., Bridges, J. D., Sobczeck, M., Gray, J.,
Linnoila, R. I., Gazdar, A. F., Hankins, L., Steinberg, S. M., Edison, M., Frame, J. N.,
Pass, H., Nesbitt, J., Holden, D., Mulshine, J. L., Glatstein, E., and Ihde, D. C.
Patients with limited-stage small-cell lung cancer treated with concurrent twice-daily
chest radiotherapy and etoposide/cisplatin followed by cyclophosphamide, doxorubicin, and
vincristine. J Clin Oncol, 14: 806-813, 1996.
78. Izraeli, S., Mueller, B. U., Ling, A., Temeck, B. K.,
Lewis, L. L., Chang, R., Shad, A. T., Pass, H. I., and Pizzo, P. A. Role of tissue
diagnosis in pulmonary involvement in pediatric human immunodeficiency virus infection.
Pediatr.Infect.Dis.J, 15: 112-116, 1996.
79. Shaw, G. L., Gazdar, A. F., Phelps, R., Steinberg, S. M.,
Linnoila, R. I., Johnson, B. E., Oie, H. K., Russell, E. K., Ghosh, B. C., Pass, H. I.,
Minna, J. D., Mulshine, J. L., and Ihde, D. C. Correlation of in vitro drug sensitivity
testing results with response to chemotherapy and survival: comparison of non-small cell
lung cancer and small cell lung cancer. J Cell Biochem.Suppl, 24: 173-185, 1996.
80. Pass, H. I. and Mew, D. J. In vitro and in vivo studies
of mesothelioma. J Cell Biochem.Suppl, 24: 142-151, 1996.
81. Pass, H. I., Kennedy, R. C., and Carbone, M. Evidence for
and implications of SV40-like sequences in human mesotheliomas. Important Adv.Oncol,
89-108, 1996.
82. Penno, M. B., Askin, F. B., Ma, H., Carbone, M., Vargas,
M. P., and Pass, H. I. High CD44 Expression on Human Mesotheliomas Mediates Association
with Hyaluronan. Cancer J Sci.Am., 1: 196, 1995.
83. Pass, H. I. and Donington, J. S. Use of photodynamic
therapy for the management of pleural malignancies. Semin.Surg.Oncol, 11: 360-367,
1995.
84. Donington, J. S., Mew, D. J., and Pass, H. I. Malignant
pleural mesothelioma: newer aspects of carcinogenesis, molecular genetics, and prospects
for future therapies. Surg.Oncol, 4: 175-185, 1995.
85. Theodossiou, C., Temeck, B., Vargas, H., Yang, J.,
Vargas, M., Hahn, S., and Pass, H. Cytomegalovirus enteritis after treatment with
5-fluorouracil, leukovorin, cisplatin, and alpha-interferon. Am.J Gastroenterol.,
90:
1174-1176, 1995.
86. Temeck, B. K., Wexler, L. H., Steinberg, S. M., McClure,
L. L., Horowitz, M., and Pass, H. I. Metastasectomy for sarcomatous pediatric histologies:
results and prognostic factors. Ann.Thorac.Surg., 59: 1385-1389, 1995.
87. Alexander, H. R., Grem, J. L., Hamilton, J. M., Pass, H.
I., Hong, M., Fraker, D. L., Steinberg, S. M., McAtee, N., Allegra, C. J., and Johnston,
P. G. Thymidylate Synthase Protein Expression. Cancer J Sci.Am., 1: 49, 1995.
88. Pass, H. W., Temeck, B. K., Kranda, K., Steinberg, S. M.,
and Pass, H. I. A phase II trial investigating primary immunochemotherapy for malignant
pleural mesothelioma and the feasibility of adjuvant immunochemotherapy after maximal
cytoreduction. Ann.Surg.Oncol, 2: 214-220, 1995.
89. Pass, H. I., Stevens, E. J., Oie, H., Tsokos, M. G.,
Abati, A. D., Fetsch, P. A., Mew, D. J., Pogrebniak, H. W., and Matthews, W. J.
Characteristics of nine newly derived mesothelioma cell lines. Ann.Thorac.Surg.,
59:
835-844, 1995.
90. Sekido, Y., Pass, H. I., Bader, S., Mew, D. J.,
Christman, M. F., Gazdar, A. F., and Minna, J. D. Neurofibromatosis type 2 (NF2) gene is
somatically mutated in mesothelioma but not in lung cancer. Cancer Res.,
55:
1227-1231, 1995.
91. Temeck, B. K. and Pass, H. I. Esophagopleural fistula: a
complication of photodynamic therapy. South.Med.J, 88: 271-274, 1995.
92. Teruya-Feldstein, J., Temeck, B. K., Sloas, M. M.,
Kingma, D. W., Raffeld, M., Pass, H. I., Mueller, B., and Jaffe, E. S. Pulmonary malignant
lymphoma of mucosa-associated lymphoid tissue (MALT) arising in a pediatric HIV-positive
patient. Am.J Surg.Pathol., 19: 357-363, 1995.
93. Amin, K. M., Litzky, L. A., Smythe, W. R., Mooney, A. M.,
Morris, J. M., Mews, D. J., Pass, H. I., Kari, C., Rodeck, U., Rauscher, F. J., III, and .
Wilms' tumor 1 susceptibility (WT1) gene products are selectively expressed in malignant
mesothelioma. Am.J Pathol., 146: 344-356, 1995.
94. Pass, H. I., Mew, D., Pass, H. A., and Temeck, B. K. The
macrophage, TNF, and other cytokines. Chest Surg.Clin N.Am., 5: 73-90, 1995.
95. Yang, J. C., Fraker, D. L., Thom, A. K., Pass, H. I., and
Rosenberg, S. A. Isolation perfusion with tumor necrosis factor-alpha, interferon-gamma,
and hyperthermia in the treatment of localized and metastatic cancer. Recent Results
Cancer Res., 138: 161-166, 1995.
96. Shaw, G. L., Falk, R. T., Deslauriers, J., Frame, J. N.,
Nesbitt, J. C., Pass, H. I., Issaq, H. J., Hoover, R. N., and Tucker, M. A. Debrisoquine
metabolism and lung cancer risk. Cancer Epidemiol.Biomarkers Prev., 4: 41-48, 1995.
97. Williams, K. S., Temeck, B. K., and Pass, H. I.
Intrapericardial pheochromocytoma complicated by massive intraoperative hemorrhage.
South.Med.J, 87: 1164-1167, 1994.
98. Moskaluk, C. A., Pogrebniak, H. W., Pass, H. I., Gallin,
J. I., and Travis, W. D. Surgical pathology of the lung in chronic granulomatous disease.
Am.J Clin Pathol., 102: 684-691, 1994.
99. Shilyansky, J., Wilson, W., Temeck, B. K., and Pass, H.
I. Pulmonary artery-bronchial fistula during lymphoma treatment. J
Thorac.Cardiovasc.Surg., 108: 790-791, 1994.
100. Pass, H. I. and Pogrebniak, H. W. Potential uses of
prostaglandin E1 analog for cardiovascular disease. J Thorac.Cardiovasc.Surg.,
108:
789-790, 1994.
101. Walsh, T. J., Renshaw, G., Andrews, J., Kwon-Chung, J.,
Cunnion, R. C., Pass, H. I., Taubenberger, J., Wilson, W., and Pizzo, P. A. Invasive
zygomycosis due to Conidiobolus incongruus. Clin Infect.Dis., 19: 423-430, 1994.
102. Zeiger, M. A., Gnarra, J. R., Zbar, B., Linehan, W. M.,
and Pass, H. I. Loss of heterozygosity on the short arm of chromosome 3 in mesothelioma
cell lines and solid tumors. Genes Chromosomes.Cancer, 11: 15-20, 1994.
103. Jensen, S. M., Jones, J. E., Pass, H., Steinberg, S. M.,
and Linnoila, R. I. Clara cell 10 kDa protein mRNA in normal and atypical regions of human
respiratory epithelium. Int.J Cancer, 58: 629-637, 1994.
104. Temeck, B. K., Venzon, D. J., Moskaluk, C. A., and Pass,
H. I. Thoracotomy for pulmonary mycoses in non-HIV-immunosuppressed patients.
Ann.Thorac.Surg., 58: 333-338, 1994.
105. Pass, H. I. Contemporary approaches in the investigation
and treatment of malignant pleural mesothelioma. Chest Surg.Clin N.Am.,
4: 497-515,
1994.
106. Pass, H. I. 1987: Delivery of intraoperative radiation
therapy after pneumonectomy: experimental observations and early clinical results. Updated
in 1994. Ann.Thorac.Surg., 58: 269-270, 1994.
107. Cole, D. J., Ettinghausen, S. E., Pass, H. I., Danforth,
D. N., Linehan, M. W., Myers, C. W., Cooper, M. R., and Sindelar, W. F. Postoperative
complications in patients receiving suramin therapy. Surgery, 116: 90-95, 1994.
108. Walker, C., Rutten, F., Yuan, X., Pass, H., Mew, D. M.,
and Everitt, J. Wilms' tumor suppressor gene expression in rat and human mesothelioma.
Cancer Res., 54: 3101-3106, 1994.
109. Carbone, M., Pass, H. I., Rizzo, P., Marinetti, M., Di
Muzio, M., Mew, D. J., Levine, A. S., and Procopio, A. Simian virus 40-like DNA sequences
in human pleural mesothelioma. Oncogene, 9: 1781-1790, 1994.
110. Pogrebniak, H. W., Witt, C. J., Terrill, R., Kranda, K.,
Travis, W. D., Rosenberg, S. A., and Pass, H. I. Isolated lung perfusion with tumor
necrosis factor: a swine model in preparation of human trials. Ann.Thorac.Surg.,
57:
1477-1483, 1994.
111. Pass, H. I. Malignant pleural mesothelioma: the thoracic
surgeon and gene therapy. Ann.Thorac.Surg., 57: 1383-1384, 1994.
112. Temeck, B. K. and Pass, H. I. A method to facilitate
subxiphoid pericardiotomy. Ann.Thorac.Surg., 57: 1015-1017, 1994.
113. Mulshine, J. L., Johnson, B. E., Gazdar, A. F., Shaw, G.
L., Kramer, B. S., Mitsudomi, T., Minna, J. D., Pass, H., Phelps, R., Ghosh, B., and .
Integrated clinical and basic studies related to circumventing non-small cell lung cancer
drug resistance. Lung Cancer, 10 Suppl 1: S73-S81, 1994.
114. Dichek, H. L., Nieman, L. K., Oldfield, E. H., Pass, H.
I., Malley, J. D., and Cutler, G. B., Jr. A comparison of the standard high dose
dexamethasone suppression test and the overnight 8-mg dexamethasone suppression test for
the differential diagnosis of adrenocorticotropin-dependent Cushing's syndrome. J Clin
Endocrinol.Metab, 78: 418-422, 1994.
115. Prewitt, T. W., Matthews, W., Chaudhri, G., Pogrebniak,
H. W., and Pass, H. I. Tumor necrosis factor induces doxorubicin resistance to lung cancer
cells in vitro. J Thorac.Cardiovasc.Surg., 107: 43-49, 1994.
116. Tochner, Z. A., Pass, H. I., Smith, P. D., DeLaney, T.
F., Sprague, M., DeLuca, A. M., Harrington, F., Thomas, G. F., Terrill, R., Bacher, J. D.,
and . Intrathoracic photodynamic therapy: a canine normal tissue tolerance study and early
clinical experience. Lasers Surg.Med., 14: 118-123, 1994.
117. Pass, H. I., DeLaney, T. F., Tochner, Z., Smith, P. E.,
Temeck, B. K., Pogrebniak, H. W., Kranda, K. C., Russo, A., Friauf, W. S., Cole, J. W.,
and . Intrapleural photodynamic therapy: results of a phase I trial. Ann.Surg.Oncol,
1:
28-37, 1994.
118. Zeiger, M. A., Fraker, D. L., Pass, H. I., Nieman, L.
K., Cutler, G. B., Jr., Chrousos, G. P., and Norton, J. A. Effective reversibility of the
signs and symptoms of hypercortisolism by bilateral adrenalectomy. Surgery,
114:
1138-1143, 1993.
119. Sheppard, B. C., Temeck, B. K., Taubenberger, J. K., and
Pass, H. I. Pulmonary metastatic disease in ameloblastoma. Chest, 104: 1933-1935,
1993.
120. Prewitt, T. W., Lubensky, I. A., Pogrebniak, H. W., and
Pass, H. I. Orthotopic implantation of mesothelioma in the pneumonectomized
immune-deficient rat: a model for innovative therapies. Int.J Cancer, 55: 877-880,
1993.
121. Shaw, G. L., Gazdar, A. F., Phelps, R., Linnoila, R. I.,
Ihde, D. C., Johnson, B. E., Oie, H. K., Pass, H. I., Steinberg, S. M., Ghosh, B. C., and
. Individualized chemotherapy for patients with non-small cell lung cancer determined by
prospective identification of neuroendocrine markers and in vitro drug sensitivity
testing. Cancer Res., 53: 5181-5187, 1993.
122. Pass, H. I. and Pogrebniak, H. W. Malignant pleural
mesothelioma. Curr.Probl.Surg., 30: 921-1012, 1993.
123. Walther, M. M., Alexander, R. B., Weiss, G. H., Venzon,
D., Berman, A., Pass, H. I., Linehan, W. M., and Rosenberg, S. A. Cytoreductive surgery
prior to interleukin-2-based therapy in patients with metastatic renal cell carcinoma.
Urology, 42: 250-257, 1993.
124. Pogrebniak, H. W., Lubensky, I. A., and Pass, H. I.
Differential expression of platelet derived growth factor-beta in malignant mesothelioma:
a clue to future therapies? Surg.Oncol, 2: 235-240, 1993.
125. Long, J. P., Choyke, P. L., Shawker, T. A., Robertson,
C. A., Pass, H. I., Walther, M. M., and Linehan, W. M. Intraoperative ultrasound in the
evaluation of tumor involvement of the inferior vena cava. J Urol., 150: 13-17,
1993.
126. Broers, J. L., Viallet, J., Jensen, S. M., Pass, H.,
Travis, W. D., Minna, J. D., and Linnoila, R. I. Expression of c-myc in progenitor cells
of the bronchopulmonary epithelium and in a large number of non-small cell lung cancers.
Am.J Respir.Cell Mol.Biol., 9: 33-43, 1993.
127. Prewitt, T. W. and Pass, H. I. Photodynamic therapy for
thoracic cancer: biology and applications. Semin.Thorac.Cardiovasc.Surg.,
5:
229-237, 1993.
128. Alexander, H. R., Grem, J. L., Pass, H. I., Hamilton,
M., McAtee, N., Fraker, D. L., and Allegra, C. J. Neoadjuvant chemotherapy for locally
advanced gastric adenocarcinoma. Oncology (Huntingt), 7: 37-42, 1993.
129. Pogrebniak, H. W., Gallin, J. I., Malech, H. L., Baker,
A. R., Moskaluk, C. A., Travis, W. D., and Pass, H. I. Surgical management of pulmonary
infections in chronic granulomatous disease of childhood. Ann.Thorac.Surg.,
55:
844-849, 1993.
130. Pass, H. I. Photodynamic therapy in oncology: mechanisms
and clinical use. J Natl.Cancer Inst., 85: 443-456, 1993.
131. Pogrebniak, H. W. and Pass, H. I. Initial and
reoperative pulmonary metastasectomy: indications, technique, and results.
Semin.Surg.Oncol, 9: 142-149, 1993.
132. Allende, M., Pizzo, P. A., Horowitz, M., Pass, H. I.,
and Walsh, T. J. Pulmonary cryptococcosis presenting as metastases in children with
sarcomas. Pediatr.Infect.Dis.J, 12: 240-243, 1993.
133. Pogrebniak, H. W., Matthews, W., Black, C., Russo, A.,
Mitchell, J. B., Smith, P., Roth, J. A., and Pass, H. I. Targetted phototherapy with
sensitizer-monoclonal antibody conjugate and light. Surg.Oncol, 2: 31-42, 1993.
134. Zeiger, M. A., Pass, H. I., Doppman, J. D., Nieman, L.
K., Chrousos, G. P., Cutler, G. B., Jr., Jensen, R. T., and Norton, J. A. Surgical
strategy in the management of non-small cell ectopic adrenocorticotropic hormone syndrome.
Surgery, 112: 994-1000, 1992.
135. Medeiros, L. J., Anasti, J., Gardner, K. L., Pass, H.
I., and Nieman, L. K. Virilizing adrenal cortical neoplasm arising ectopically in the
thorax. J Clin Endocrinol.Metab, 75: 1522-1525, 1992.
136. Pogrebniak, H. W., Merino, M. J., Hahn, S. M., Mitchell,
J. B., and Pass, H. I. Spin trap salvage from endotoxemia: the role of cytokine
down-regulation. Surgery, 112: 130-139, 1992.
137. Doppman, J. L., Pass, H. I., Nieman, L. K., Miller, D.
L., Chang, R., Cutler, G. B., Jr., Chrousos, G. P., Jaffe, G. S., and Norton, J. A.
Corticotropin-secreting carcinoid tumors of the thymus: diagnostic unreliability of thymic
venous sampling. Radiology, 184: 71-74, 1992.
138. Pogrebniak, H. W., Haas, G., Linehan, W. M., Rosenberg,
S. A., and Pass, H. I. Renal cell carcinoma: resection of solitary and multiple
metastases. Ann.Thorac.Surg., 54: 33-38, 1992.
139. Pass, H. I. and Pogrebniak, H. Photodynamic therapy for
thoracic malignancies. Semin.Surg.Oncol, 8: 217-225, 1992.
140. Pass, H. I., Pogrebniak, H. W., Steinberg, S. M.,
Mulshine, J., and Minna, J. Randomized trial of neoadjuvant therapy for lung cancer:
interim analysis. Ann.Thorac.Surg., 53: 992-998, 1992.
141. Jensen, J. C., Pogrebniak, H. W., Pass, H. I., Buresh,
C., Merino, M. J., Kauffman, D., Venzon, D., Langstein, H. N., and Norton, J. A. Role of
tumor necrosis factor in oxygen toxicity. J Appl.Physiol, 72: 1902-1907, 1992.
142. Sherry, R. M., Pass, H. I., Rosenberg, S. A., and Yang,
J. C. Surgical resection of metastatic renal cell carcinoma and melanoma after response to
interleukin-2-based immunotherapy. Cancer, 69 : 1850-1855, 1992.
143. Pogrebniak, H. W., Matthews, W., and Pass, H. I.
Alterations in macrophage free radical and tumor necrosis factor production by a potassium
channel activator. J Surg.Res., 52: 395-400, 1992.
144. Chang, K., Pai, L. H., Pass, H., Pogrebniak, H. W.,
Tsao, M. S., Pastan, I., and Willingham, M. C. Monoclonal antibody K1 reacts with
epithelial mesothelioma but not with lung adenocarcinoma. Am.J Surg.Pathol.,
16:
259-268, 1992.
145. Broers, J. L., Jensen, S. M., Travis, W. D., Pass, H.,
Whitsett, J. A., Singh, G., Katyal, S. L., Gazdar, A. F., Minna, J. D., and Linnoila, R.
I. Expression of surfactant associated protein-A and Clara cell 10 kilodalton mRNA in
neoplastic and non-neoplastic human lung tissue as detected by in situ hybridization. Lab
Invest, 66: 337-346, 1992.
146. Cook, J. A., Glass, J., Lebovics, R., Bobo, H., Pass,
H., DeLaney, T. F., Oldfield, E. H., Mitchell, J. B., Glatstein, E., and Goffman, T. E.
Measurement of thymidine replacement in patients with high grade gliomas, head and neck
tumors, and high grade sarcomas after continuous intravenous infusions of
5-iododeoxyuridine. Cancer Res., 52: 719-725, 1992.
147. Doherty, G. M., Doppman, J. L., Miller, D. L., Gee, M.
S., Marx, S. J., Spiegel, A. M., Aurbach, G. D., Pass, H. I., Brennan, M. F., and Norton,
J. A. Results of a multidisciplinary strategy for management of mediastinal parathyroid
adenoma as a cause of persistent primary hyperparathyroidism. Ann.Surg.,
215:
101-106, 1992.
148. Feuerstein, I. M., Jicha, D. L., Pass, H. I., Chow, C.
K., Chang, R., Ling, A., Hill, S. C., Dwyer, A. J., Travis, W. D., Horowitz, M. E., and .
Pulmonary metastases: MR imaging with surgical correlation--a prospective study.
Radiology, 182: 123-129, 1992.
149. Kenney, R. T., Kwon-Chung, K. J., Waytes, A. T.,
Melnick, D. A., Pass, H. I., Merino, M. J., and Gallin, J. I. Successful treatment of
systemic Exophiala dermatitidis infection in a patient with chronic granulomatous disease.
Clin Infect.Dis., 14: 235-242, 1992.
150. Tochner, Z. A., Pass, H. I., Sindelar, W. F., DeLuca, A.
M., Grisell, D. L., Bacher, J. D., and Kinsella, T. J. Long term tolerance of thoracic
organs to intraoperative radiotherapy. Int.J Radiat.Oncol Biol.Phys., 22: 65-69,
1992.
151. Pogrebniak, H. W., Prewitt, T. W., Matthews, W. A., and
Pass, H. I. Tumor necrosis factor-alpha alters response of lung cancer cells to oxidative
stress. J Thorac.Cardiovasc.Surg., 102: 904-907, 1991.
152. Travis, W. D., Kwon-Chung, K. J., Kleiner, D. E., Geber,
A., Lawson, W., Pass, H. I., and Henderson, D. Unusual aspects of allergic
bronchopulmonary fungal disease: report of two cases due to Curvularia organisms
associated with allergic fungal sinusitis. Hum.Pathol., 22: 1240-1248, 1991.
153. Pass, H. I. Bronchial adenoma. Ann.Thorac.Surg.,
52:
1201-1203, 1991.
154. Mitsudomi, T., Steinberg, S. M., Oie, H. K., Mulshine,
J. L., Phelps, R., Viallet, J., Pass, H., Minna, J. D., and Gazdar, A. F. ras gene
mutations in non-small cell lung cancers are associated with shortened survival
irrespective of treatment intent. Cancer Res., 51: 4999-5002, 1991.
155. Cook, J. A., Pass, H. I., Iype, S. N., Friedman, N.,
DeGraff, W., Russo, A., and Mitchell, J. B. Cellular glutathione and thiol measurements
from surgically resected human lung tumor and normal lung tissue. Cancer Res.,
51:
4287-4294, 1991.
156. Pogrebniak, H. W., Roth, J. A., Steinberg, S. M.,
Rosenberg, S. A., and Pass, H. I. Reoperative pulmonary resection in patients with
metastatic soft tissue sarcoma. Ann.Thorac.Surg., 52: 197-203, 1991.
157. Pogrebniak, H. W., Matthews, W., and Pass, H. I.
Chemotherapy amplifies production of tumor necrosis factor. Surgery, 110: 231-237,
1991.
158. Travis, W. D., Linnoila, R. I., Tsokos, M. G.,
Hitchcock, C. L., Cutler, G. B., Jr., Nieman, L., Chrousos, G., Pass, H., and Doppman, J.
Neuroendocrine tumors of the lung with proposed criteria for large-cell neuroendocrine
carcinoma. An ultrastructural, immunohistochemical, and flow cytometric study of 35 cases.
Am.J Surg.Pathol., 15: 529-553, 1991.
159. Pogrebniak, H., Matthews, W., Mitchell, J., Russo, A.,
Samuni, A., and Pass, H. Spin trap protection from tumor necrosis factor cytotoxicity. J
Surg.Res., 50: 469-474, 1991.
160. Jensen, J. C., Choyke, P. L., Rosenfeld, M., Pass, H.
I., Keiser, H., White, B., Travis, W., and Linehan, W. M. A report of familial carotid
body tumors and multiple extra-adrenal pheochromocytomas. J Urol., 145: 1040-1042,
1991.
161. Pass, H. I., Evans, S., Matthews, W. A., Perry, R.,
Venzon, D., Roth, J. A., and Smith, P. Photodynamic therapy of oncogene-transformed cells.
J Thorac.Cardiovasc.Surg., 101: 795-799, 1991.
162. Travis, W. D., Hoffman, G. S., Leavitt, R. Y., Pass, H.
I., and Fauci, A. S. Surgical pathology of the lung in Wegener's granulomatosis. Review of
87 open lung biopsies from 67 patients. Am.J Surg.Pathol., 15: 315-333, 1991.
163. Jensen, J. C., Pass, H. I., Sindelar, W. F., and Norton,
J. A. Recurrent or metastatic disease in select patients with adrenocortical carcinoma.
Aggressive resection vs chemotherapy. Arch.Surg., 126: 457-461, 1991.
164. Perry, R. R., Smith, P. D., Evans, S., and Pass, H. I.
Intravenous vs intraperitoneal sensitizer: implications for intraperitoneal photodynamic
therapy. Photochem.Photobiol., 53: 335-340, 1991.
165. Doppman, J. L., Pass, H. I., Nieman, L. K., Findling, J.
W., Dwyer, A. J., Feuerstein, I. M., Ling, A., Travis, W. D., Cutler, G. B., Jr.,
Chrousos, G. P., and . Detection of ACTH-producing bronchial carcinoid tumors: MR imaging
vs CT. AJR Am.J Roentgenol., 156: 39-43, 1991.
166. Pass, H. I. Symposium on thoracic surgical oncology.
Ann.Thorac.Surg., 51: 163, 1991.
167. Perry, R. R., Keiser, H. R., Norton, J. A., Wall, R. T.,
Robertson, C. N., Travis, W., Pass, H. I., Walther, M. M., and Linehan, W. M. Surgical
management of pheochromocytoma with the use of metyrosine. Ann.Surg., 212: 621-628,
1990.
168. Pass, H. I., Tochner, Z., DeLaney, T., Smith, P.,
Friauf, W., Glatstein, E., and Travis, W. Intraoperative photodynamic therapy for
malignant mesothelioma. Ann.Thorac.Surg., 50: 687-688, 1990.
169. Wall, R. T., Buzzanell, C. A., Epstein, T. A., Malech,
H. L., Melnick, D., Pass, H. I., and Gallin, J. I. Anesthetic considerations in patients
with chronic granulomatous disease. J Clin Anesth., 2: 306-311, 1990.
170. Robertson, C. N., Linehan, W. M., Pass, H. I., Gomella,
L. G., Haas, G. P., Berman, A., Merino, M., and Rosenberg, S. A. Preparative cytoreductive
surgery in patients with metastatic renal cell carcinoma treated with adoptive
immunotherapy with interleukin-2 or interleukin-2 plus lymphokine activated killer cells.
J Urol., 144: 614-617, 1990.
171. Perry, R. R., Matthews, W., Mitchell, J. B., Russo, A.,
Evans, S., and Pass, H. I. Sensitivity of different human lung cancer histologies to
photodynamic therapy. Cancer Res., 50: 4272-4276, 1990.
172. Travis, W. D., Pittaluga, S., Lipschik, G. Y., Ognibene,
F. P., Suffredini, A. F., Masur, H., Feuerstein, I., Kovacs, J., Pass, H. I., Condron, K.
S., and . Atypical pathologic manifestations of Pneumocystis carinii pneumonia in the
acquired immune deficiency syndrome. Review of 123 lung biopsies from 76 patients with
emphasis on cysts, vascular invasion, vasculitis, and granulomas. Am.J Surg.Pathol.,
14:
615-625, 1990.
173. Pass, H. I., Doppman, J. L., Nieman, L., Stovroff, M.,
Vetto, J., Norton, J. A., Travis, W., Chrousos, G. P., Oldfield, E. H., and Cutler, G. B.,
Jr. Management of the ectopic ACTH syndrome due to thoracic carcinoids. Ann.Thorac.Surg.,
50:
52-57, 1990.
174. Perry, R. R., Venzon, D., Roth, J. A., and Pass, H. I.
Survival after surgical resection for high-grade chest wall sarcomas. Ann.Thorac.Surg.,
49:
363-368, 1990.
175. Feurestein, I. M., Archer, A., Pluda, J. M., Francis, P.
S., Falloon, J., Masur, H., Pass, H. I., and Travis, W. D. Thin-walled cavities, cysts,
and pneumothorax in Pneumocystis carinii pneumonia: further observations with
histopathologic correlation. Radiology, 174: 697-702, 1990.
176. Evans, S., Matthews, W., Perry, R., Fraker, D., Norton,
J., and Pass, H. I. Effect of photodynamic therapy on tumor necrosis factor production by
murine macrophages. J Natl.Cancer Inst., 82: 34-39, 1990.
177. Pass, H. I. and Reed, C. E. Lasers in the management of
upper aerodigestive malignancies. Important Adv.Oncol, 159-179, 1990.
178. Doppman, J. L., Pass, H. I., Nieman, L., Cutler, G. B.,
Jr., Chrousos, G. P., and Loriaux, D. L. Failure of bronchial lavage to detect elevated
levels of adrenocorticotropin (ACTH) in patients with ACTH-producing bronchial carcinoids.
J Clin Endocrinol.Metab, 69: 1302-1304, 1989.
179. Takahashi, T., Nau, M. M., Chiba, I., Birrer, M. J.,
Rosenberg, R. K., Vinocour, M., Levitt, M., Pass, H., Gazdar, A. F., and Minna, J. D. p53:
a frequent target for genetic abnormalities in lung cancer. Science, 246: 491-494,
1989.
180. Horan, J. J., Robertson, C. N., Choyke, P. L., Frank, J.
A., Miller, D. L., Pass, H. I., and Linehan, W. M. The detection of renal carcinoma
extension into the renal vein and inferior vena cava: a prospective comparison of
venacavography and magnetic resonance imaging. J Urol., 142: 943-947, 1989.
181. Matthews, W., Rizzoni, W., Mitchell, J., Russo, A., and
Pass, H. In vitro photodynamic therapy of human lung cancer. J Surg.Res.,
47:
276-281, 1989.
182. Doppman, J. L., Nieman, L., Miller, D. L., Pass, H. I.,
Chang, R., Cutler, G. B., Jr., Schaaf, M., Chrousos, G. P., Norton, J. A., Ziessman, H.
A., and . Ectopic adrenocorticotropic hormone syndrome: localization studies in 28
patients. Radiology, 172: 115-124, 1989.
183. Perry, R. R., Rosenberg, R. K., and Pass, H. I.
Tracheoesophageal fistula in the patient with lymphoma: case report and review of the
literature. Surgery, 105: 770-777, 1989.
184. Rosengart, T. K., Pass, H., Cannon, R., Miller, D. L.,
Solomon, D., and Clark, R. E. Ruptured gastroepiploic artery aneurysm and vascular
collapse in a patient with thoracic aneurysm. J Cardiovasc.Surg.(Torino),
30:
514-516, 1989.
185. Cook, J. A., Pass, H. I., Russo, A., Iype, S., and
Mitchell, J. B. Use of monochlorobimane for glutathione measurements in hamster and human
tumor cell lines. Int.J Radiat.Oncol Biol.Phys., 16 : 1321-1324, 1989.
186. Jablons, D., Steinberg, S. M., Roth, J., Pittaluga, S.,
Rosenberg, S. A., and Pass, H. I. Metastasectomy for soft tissue sarcoma. Further evidence
for efficacy and prognostic indicators. J Thorac.Cardiovasc.Surg., 97: 695-705,
1989.
187. Pass, H. I., DeLaney, T., Smith, P. D., Bonner, R., and
Russo, A. Bronchoscopic phototherapy at comparable dose rates: early results.
Ann.Thorac.Surg., 47: 693-699, 1989.
188. Perry, R. R., Evans, S., Matthews, W., Rizzoni, W.,
Russo, A., and Pass, H. I. Potentiation of phototherapy cytotoxicity with light scattering
media. J Surg.Res., 46: 386-390, 1989.
189. Matthews, W., Cook, J., Mitchell, J. B., Perry, R. R.,
Evans, S., and Pass, H. I. In vitro photodynamic therapy of human lung cancer:
investigation of dose-rate effects. Cancer Res., 49: 1718-1721, 1989.
190. Rex, J. H., Ginsberg, A. M., Fries, L. F., Pass, H. I.,
and Kwon-Chung, K. J. Cunninghamella bertholletiae infection associated with deferoxamine
therapy. Rev.Infect.Dis., 10: 1187-1194, 1988.
191. Lefor, A. T., Merino, M. M., Steinberg, S. M., Dwyer,
A., Roth, J. A., Flanagan, M., and Pass, H. I. Computerized tomographic prediction of
extraluminal spread and prognostic implications of lesion width in esophageal carcinoma.
Cancer, 62: 1287-1292, 1988.
192. Sindelar, W. F., Hoekstra, H. J., Kinsella, T. J.,
Barnes, M., DeLuca, A. M., Tochner, Z., Pass, H. I., Kranda, K. C., and Terrill, R. E.
Response of canine esophagus to intraoperative electron beam radiotherapy. Int.J
Radiat.Oncol Biol.Phys., 15: 663-669, 1988.
193. Travis, W. D., Linnoila, R. I., Horowitz, M., Becker, R.
L., Jr., Pass, H., Ozols, R., and Gazdar, A. Pulmonary nodules resembling
bronchioloalveolar carcinoma in adolescent cancer patients. Mod.Pathol.,
1:
372-377, 1988.
194. Roth, J. A., Pass, H. I., Flanagan, M. M., Graeber, G.
M., Rosenberg, J. C., and Steinberg, S. Randomized clinical trial of preoperative and
postoperative adjuvant chemotherapy with cisplatin, vindesine, and bleomycin for carcinoma
of the esophagus. J Thorac.Cardiovasc.Surg., 96: 242-248, 1988.
195. Pogrebniak, H. W., Stovroff, M., Roth, J. A., and Pass,
H. I. Resection of pulmonary metastases from malignant melanoma: results of a 16-year
experience. Ann.Thorac.Surg., 46: 20-23, 1988.
196. Perry, R. R., Knego, R. S., and Pass, H. I.
Trachea-innominate artery fistula. J Thorac.Cardiovasc.Surg., 96: 184-185, 1988.
197. Ognibene, F. P., Pass, H. I., Roth, J. A., Shelhamer, J.
H., and Milne, E. N. Role of imaging and interventional techniques in the diagnosis of
respiratory disease in the immunocompromised host. J Thorac.Imaging, 3: 1-20, 1988.
198. Wiebke, E. A., McDonald, H. D., and Pass, H. I. The
infected chest wall prosthesis: management by excision and contralateral transverse rectus
abdominis musculocutaneous flap. Ann.Thorac.Surg., 44: 544-545, 1987.
199. Lanza, L. A., Miser, J. S., Pass, H. I., and Roth, J. A.
The role of resection in the treatment of pulmonary metastases from Ewing's sarcoma. J
Thorac.Cardiovasc.Surg., 94: 181-187, 1987.
200. Pass, H. I., Sindelar, W. F., Kinsella, T. J., DeLuca,
A. M., Barnes, M., Kurtzman, S., Hoekstra, H., Tochner, Z., Roth, J., and Glatstein, E.
Delivery of intraoperative radiation therapy after pneumonectomy: experimental
observations and early clinical results. Ann.Thorac.Surg., 44: 14-20, 1987.
201. Doppman, J. L., Loughlin, T., Miller, D. L., Pass, H.
I., Chrousos, G. P., Cutler, G. B., Oldfield, E. H., and Loriaux, D. L. Identification of
ACTH-producing intrathoracic tumors by measuring ACTH levels in aspirated specimens.
Radiology, 163: 501-503, 1987.
202. Wall, R. T., Pass, H. I., and McDonald, H. D. Unusual
presentation and novel solution for hemodynamic compromise during thoracic surgery.
Anesthesiology, 66: 566-568, 1987.
203. Barnes, M., Pass, H., DeLuca, A., Tochner, Z., Potter,
D., Terrill, R., Sindelar, W. F., and Kinsella, T. J. Response of the mediastinal and
thoracic viscera of the dog to intraoperative radiation therapy (IORT). Int.J Radiat.Oncol
Biol.Phys., 13: 371-378, 1987.
204. Rizzoni, W. E., Pass, H. I., Wesley, M. N., Rosenberg,
S. A., and Roth, J. A. Resection of recurrent pulmonary metastases in patients with
soft-tissue sarcomas. Arch.Surg., 121: 1248-1252, 1986.
205. Edington, H., Salwitz, J., Longo, D. L., Roth, J. A.,
and Pass, H. Thymic hyperplasia masquerading as recurrent Hodgkin's disease: case report
and review of the literature. J Surg.Oncol, 33: 120-123, 1986.
206. Roth, J. A., Pass, H. I., Wesley, M. N., White, D.,
Putnam, J. B., and Seipp, C. Comparison of median sternotomy and thoracotomy for resection
of pulmonary metastases in patients with adult soft-tissue sarcomas. Ann.Thorac.Surg.,
42:
134-138, 1986.
207. Udelsman, R., Roth, J. A., Le |
PATIENT PROFILES
